Proscia
PrivateLast Round
VC Round
Mar 19, 2025
Total Funding Raised
$96.3M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Proscia is a health care technology company that provides an AI-powered digital pathology platform designed to accelerate cancer research and improve diagnostic workflows.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical AI, Drug Discovery, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Data as a Service, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Proscia Comparables
Compare Proscia with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Indica Labs | 90% | |
| Techcyte, Inc. | 88% | |
| Tempus | 85% | |
Proscia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 19, 2025 | ||||
| Series C Extension | Mar 14, 2024 | ||||
| Series C | Dec 29, 2023 | ||||
| Series C | Jun 14, 2022 | ||||
| Series B | Dec 1, 2020 | ||||
Series A | Sep 26, 2018 |
Key People
Founding team and executive leadership
Proscia Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| avenuealtd.com | VC Round |
| Flybridge | Series A |
| TCP Venture Capital | Seed |
| Emerald Development Managers | Series C, VC Round, Series A, Seed |
| Fusion Fund | VC Round, Series A |
| Triangle Peak Partners | Series C, Series C Extension, VC Round |
| HV Fund | Series B, Series C, Series C Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors increased 45% MoM.
- Jan 1, 2026
Named "Best in KLAS for Digital Pathology in Europe" and top performer in the U.S.
Proscia Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Proscia's valuation, stock price, and market status.